23561 - 23580 of 39055 results
- Peter Luijten started as vice-dean for the strategic theme Life SciencesInterview with Peter Luijten, on the occasion of his appointment as vice dean of the Life Sciences Strategic Theme on 1 October 2021/en/achtergrond/peter-luijten-started-as-vice-dean-for-the-strategic-theme-life-sciences
- Linking PinCyrille Krul describes how her team at HU contributes towards animal-free research/en/background/linking-pin
- The power of collaborationDebby Weijers believes in the power of collaboration on the road toward replacement of animal testing/en/background/the-power-of-collaboration
- We are becoming increasingly interwovenTNO collaborates with UU and HU within the Utrecht Advanced in Vitro Models Hub/en/background/we-are-becoming-increasingly-interwoven
- Mini-organs predict the effect of drugs on cystic fibrosisUtrecht researchers have demonstrated that a mini-organ grown outside the body can be used to predict the effectiveness of drugs./en/publication/mini-organs-predict-the-effect-of-drugs-on-cystic-fibrosis
- How PhD candidate Paul Jochems is valorising his researchPhD candidate Paul Jochems developed a reliable gut model to study the uptake of various proteins. Now he is spinning it out as a business./en/achtergrond/how-phd-candidate-paul-jochems-is-valorising-his-research
- Shrinking gels and growing researchersScience blog: Carl Schuurmans and Anne Metje van Genderen talk about their collaborative research experience at Harvard, USA./en/news/shrinking-gels-and-growing-researchers
- Medicijnonderzoek: nieuwe stof ontdekt die Parkinson kan remmenEen stofje dat bij muizen de ziekte van Parkinson remt, brengt de ontwikkeling van een nieuw geneesmiddel tegen de ziekte dichterbij./nieuws/medicijnonderzoek-nieuwe-stof-ontdekt-die-parkinson-kan-remmen
- Pharmaceutical research: newly discovered substance can inhibit Parkinson’sA new substance that inhibits Parkinson’s disease in mice brings researchers one step closer to developing a new drug to fight the disease./en/news/pharmaceutical-research-newly-discovered-substance-can-inhibit-parkinsons
- Minder bijwerkingen medicatie door testen op DNAPatiënten van wie de behandeling met geneesmiddelen wordt afgestemd op hun DNA, hebben 30 procent minder last van ernstige bijwerkingen./nieuws/minder-bijwerkingen-medicatie-door-testen-op-dna
- Fewer side effects of medication through DNA testingPatients whose drug treatment is matched to their DNA, suffer 30 percent fewer serious side effects./en/news/fewer-side-effects-of-medication-through-dna-testing
- Chemo-enzymatic synthesis of O-acetylated silica acids gives new insight in virus-host interactionsOn April 13, 2022, Zeshi (Jack) Li has received his doctorate with the distinction Cum Laude for Chemo-enzymatic synthesis of O-acetylated silica acids gives new insight in virus-host interactions/en/news/chemo-enzymatic-synthesis-of-o-acetylated-silica-acids-gives-new-insight-in-virus-host-interactions
- Looking back on a successful eventScience for Life looks back on a successful conference/en/news/looking-back-on-a-successful-event
- Successful first David de Wied colloquiumLectures from Robb de Vries and Albert Heck, as well as champagne, form the kick-off of these monthly UIPS meetings./en/news/successfull-first-david-de-wied-colloquium
- First UU researchers are working mobile using MyWorkplaceMyWorkplace has recently been extended to include a research environment for the Department of Pharmaceutical Sciences./en/news/first-uu-researchers-are-working-mobile-using-myworkplace
- Oratie Roos Masereeuw op 7 september: Zo goed als nieuw – een andere kijk op de farmacologieHoogleraar experimentele farmacologie bestudeert repareren van weefsel/nieuws/oratie-roos-masereeuw-zo-goed-als-nieuw-een-andere-kijk-op-de-farmacologie
- EU invests 10 million euro in key technologies in structural biologyThe EU has invested 10 million euro in the project iNEXT-Discovery, for access to structural biology facilities./en/news/eu-invests-10-million-euro-in-key-technologies-in-structural-biology
- Subsidie van Alzheimer Nederland voor Utrechtse eiwitonderzoekerStefan Rüdiger ontvangt € 200.000 voor onderzoek naar de aggregatie van het Tau-eiwit, een kenmerk van de ziekte van Alzheimer./nieuws/subsidie-van-alzheimer-nederland-voor-utrechtse-eiwitonderzoeker
- Grant from Alzheimer Nederland for Utrecht protein scientistStefan Rüdiger has been granted € 200,000 in funding for research on the aggregation of the Tau protein, a hallmark of Alzheimer’s disease./en/news/grant-from-alzheimer-nederland-for-utrecht-protein-scientist
- A changing culture in postgraduate educationInterview with Wouter Dhert, Chair Board of Studies Graduate School of Life Sciences/en/news/a-changing-culture-in-postgraduate-education